Bausch Health
BHC
#4661
Rank
NZ$3.50 B
Marketcap
NZ$9.46
Share price
-0.70%
Change (1 day)
-26.39%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

EPS for Bausch Health (BHC)

EPS in 2025 (TTM): NZ$1.65

According to Bausch Health 's latest financial reports the company's current EPS (TTM) is NZ$1.62. In 2024 the company made an earnings per share (EPS) of NZ-$0.20 an increase over its 2023 EPS that were of NZ-$2.71.

EPS history for Bausch Health from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$1.65-920.44%
2024NZ-$0.20-92.59%
2023NZ-$2.71160.89%
2022NZ-$1.04-76.64%
2021NZ-$4.4468.45%
2020NZ-$2.64-68.91%
2019NZ-$8.48-57.11%
2018NZ-$19.78-272.22%
2017NZ$11.49-199.29%
2016NZ-$11.57798.7%
2015NZ-$1.29-128.31%
2014NZ$4.55-204.62%
2013NZ-$4.35602.7%
2012NZ-$0.62

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
NZ-$0.40-124.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
NZ-$1.59-197.94%๐Ÿ‡บ๐Ÿ‡ธ USA